Transcription of the inositol polyphosphate 1-phosphatase gene (INPP1) is upregulated in human colorectal cancer

Molecular Carcinogenesis

Volumn 27, Issue 4, 2000, Pages 322-329

  Li, Shu Rui ^a,b   Gyselman, Valerie G ^a   Lalude, Olutunde ^a   Dorudi, Sina ^a   Bustin, Stephen A ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Differential gene expression; Inositol polyphosphate 1 phosphatase; Quantitative RT PCR; Suppression subtractive hybridization

Indexed keywords

DNA FRAGMENT; GENE PRODUCT; INOSITOL POLYPHOSPHATE;

ARTICLE; CATALYSIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYDROLYSIS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

COLORECTAL NEOPLASMS; HUMANS; NUCLEIC ACID HYBRIDIZATION; PHOSPHORIC MONOESTER HYDROLASES; SUBTRACTION TECHNIQUE; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0034113054     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200004)27:4<322::AID-MC10>3.0.CO;2-C     Document Type: Article

References (45)

1. Fields C, Adams MD, White O, Venter JC. How many genes in the human genome? Nat Genet 1994;7:345-346.
2. Sager R. Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci USA 1997;94: 952-955.
3. Matz MV, Lukyanov SA. Different strategies of differential display: areas of application. Nucleic Acids Res 1998;26: 5537-5543.
4. Soares MB. Identification and cloning of differentially expressed genes. Curr Opin Biotechnol 1997;8:542-546.
5. Ligon AH, Pershouse MA, Jasser S, Hong YK, Yung WK, Steck PA. Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity. J Neurovirol 1998;4:217-226.
6. Hubank M, Schatz DG. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994;22:5640-5648.
7. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995;270:484-487.
8. Siebert PD, Chenchik A, Kellogg DE, Lukyanov KA, Lukyanov SA. An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 1995;23: 1087-1088.
9. Diatchenko L, Lau YF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996;93:6025-6030.
10. Office for Population Census Studies. Mortality statistics, cause. Her Majesty's Stationery Office 1993;Series DH2.
11. Lynch HT, Lynch JF. Genetics of colonic cancer. Digestion 1998;59:481-492.
12. Khoo HE, Ho CL, Chhatwal VJ, Chan ST, Ngoi SS, Moochhala SM. Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett 1996;106:17-21.
13. DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996;110:1259-1262.
14. Mou L, Miller H, Li J, Wang E, Chalifour L. Improvements to the differential display method for gene analysis. Biochem Biophys Res Commun 1994;199:564-569.
15. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-410.
16. Steen VM, Lovlie R, Osher Y, Belmaker RH, Berle JO, Gulbrandsen A: The polymorphic inositol polyphosphate 1-phosphatase genes as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 1998 Jun;8(3):259-268.
17. Bustin SA, Gyselman VG, Williams NS, Dorudi S. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999;79: 1813-1820.
18. Rubin H. Cancer as a dynamic developmental disorder. Cancer Res 1985;45:2935-2942.
19. Rubin H. On the nature of enduring modifications induced in cells and organisms. Am J Physiol 1990;258:L19-L24.
20. Farber E, Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res 1991;51:7751-2761.
21. Zhang M, Martin KJ, Sheng S, Sager R. Expression genetics: a different approach to cancer diagnosis and prognosis. Trends Biotechnol 1998;16:66-71.
22. Bertram J, Palfner K, Hiddemann W, Kneba M. Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs 1998;9: 311-317.
23. Kuang WW, Thompson DA, Hoch RV, Weigel RJ. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 1998;26:1116-1123.
24. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA 1997;94:10057-10062.
25. Hudson C, Clements D, Friday RV, Stott D, Woodland HR. Xsox17alpha and -beta mediate endoderm formation in Xenopus. Cell 1997;91:397-405.
26. Nemeth E, Bole-Feysot C, Tashima LS. Suppression subtractive hybridization (SSH) identifies prolactin stimulation of p38 MAP kinase gene expression in Nb2 T lymphoma cells: molecular cloning of rat p38 MAP kinase. J Mol Endocrinol 1998;20:151-156.
27. von Stein OD, Thies WG, Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res 1997;25:2598-2602.
28. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272: 25190-25194.
29. Majerus PW. Inositol phosphate biochemistry. Annu Rev Biochem 1992;61:225-250.
30. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling Nature 1989;341:197-205.
31. Majerus PW, Connolly TM, Deckmyn H, et al. The metabolism of phosphoinositide-denved messenger molecules. Science 1986;234:1519-1526.
32. Cantley LC, Auger KR, Carpenter C, et al. Oncogenes and signal transduction. Cell 1991;64:281-302.
33. 2+. J Biol Chem 1987;262:15946-15952.
34. Sylvia V, Curtin G, Norman J, Stec J, Busbee D. Activation of a low specific activity form of DNA polymerase alpha by inositol-1,4-bisphosphate. Cell 1988;54:651-658.
35. Srivastava V, Tilley R, Miller S, Hart R, Busbee D. Effects of aging and dietary restriction on DNA polymerases: gene expression, enzyme fidelity, and DNA excision repair. Exp Gerontol 1992;27:593-613.
36. Burgers PM. Eukaryotic DNA polymerases in DNA replication and DNA repair. Chromosoma 1998;107:218-227
37. Togashi H, Mizushina Y, Takemura M, et al. 4-Hydroxy-17-methylincisterol, an inhibitor of DNA polymerase-alpha activity and the growth of human cancer cells in vitro. Biochem Pharmacol 1998;55:583-590.
38. Lee C, Liu M, Sie KL, Lee MS. Prostate-specific antigen promoter driven gene therapy targeting DNA polymerase-alpha and topoisomerase II alpha in prostate cancer. Anticancer Research 1996;16:1805-1811.
39. Guse AH, Greiner E, Emmrich F, Brand K. Mass changes of inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate during cell cycle progression in rat thymocytes. J Biol Chem 1993;268:7129-7133.
40. Saied IT, Shamsuddin AM. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 1998;18:1479-1484.
41. Vucenik I, Kalebic T, Tantivejkul K, Shamsuddin AM. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res 1998;18:1377-1384.
42. Noh DY, Lee YH, Kim SS, et al. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 1994;73:36-41.
43. Pongracz J, Clark P, Neoptolemos JP, Lord JM. Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int J Cancer 1995;61:35-39.
44. Kuranami M, Cohen AM, Guillem JG. Analyses of protein kinase C isoform expression in a colorectal cancer liver metastasis model. Am J Surg 1995;169:57-64.
45. Chen J, Gokhale M, Li Y, Trush MA, Yager JD. Enhanced levels of several mitochondrial mRNA transcripts and mitochondrial superoxide production during ethinyl estradiol-induced hepatocarcinogenesis and after estrogen treatment of HepG2 cells. Carcinogenesis 1998;19:2187-2193